ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Kowa Company, Ltd. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 71 studies whose lead sponsor is Kowa Company, Ltd. or one of 3 companies grouped under it. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 13, 2026.

Our grouping of 4 registry names, not the registry’s. See them and correct one ↓

Compare Kowa with Novartis and AstraZeneca →

Pipeline: 1 program

Each counted once: 1 with a study Kowa Company, Ltd. leads registered in the last two years.

  • Phase 4 (approved, new studies)

The 1 program — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Kowa Company, Ltd.’s own registered studies; Kowa Company, Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Kowa Company, Ltd.’s studies test, most open studies first — 15 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 5 more

Coming up

2 of Kowa Company, Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. 1J
  10. A
  11. 1S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 71 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now23%
  • Completed6490%
  • Stopped early57%Terminated 3 · Withdrawn 2

Phase

  • Phase 328
  • Phase 121
  • Phase 211
  • Phase 49

Where

  • United States48
  • Japan15
  • Denmark12
  • United Kingdom11
  • Germany10
  • Netherlands9

Over the years

  1. 08
  2. 09
  3. 10
  4. 11
  5. 12
  6. 13
  7. 914
  8. 15
  9. 16
  10. 17
  11. 18
  12. 19
  13. 20
  14. 21
  15. 22
  16. 23
  17. 24
  18. 25
  19. 226

By the year each study started; 10 started before 2008. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Kowa Company, Ltd.

  • Kowa Research Institute, Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    47 studies →
  • Kowa Company, Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    13 studies
  • Kowa Research Europe
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • ProEthic Pharmaceuticals
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Kowa Company, Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 71. Browse all 71 →